The collection of drugs into pharmacies is accelerating
.
According to media reports, since the beginning of this year, 161 designated retail pharmacies in Xuzhou, Jiangsu Province have passed the acceptance inspection, covering 150 townships (streets) in the city, including 138 chain retail pharmacies and 23 single retail pharmacies
.
The drugs sold cover 190 kinds of medical insurance centralized procurement drugs and 275 kinds of national negotiation drugs, all of which are sold
according to the "zero difference rate" between the centralized procurement price and the national negotiation price.
It is understood that Jiangsu Province is the first province
in the country to promote the sale of centralized drugs in retail pharmacies.
In addition to Jiangsu Province, there are also many places such as Shandong, Zhejiang, Guangdong, Henan, and Shanghai that have included pharmacies in the centralized procurement system
.
For example, in September 2021, Zibo City, Shandong Province launched the "National Centralized Procurement of Drugs into Pharmacies" campaign to realize the sales
of centralized procurement of drugs into pharmacies.
It is reported that in less than two weeks, the number of pharmacies in the city has increased from 167 to 387 from 167
.
Henan Province has also piloted the inclusion of retail pharmacies in the scope of centralized procurement, and by the end of 2021, the province had included more than
9,000 designated retail pharmacies for centralized procurement products.
It is reported that if the pilot is successful in the province, more than 20,000 designated pharmacies in the province are expected to be included
.
In the second half of this year, Yunnan Province held a symposium on "Investigation on the Innovation and Development of Retail Pharmacies' Implementation of Centralized Drug Procurement Business Model", and the participants discussed the innovation
of pharmacy's centralized drug procurement business model.
It is reported that as early as 2020, Yunnan Province issued the "Convention on the Implementation of Centralized Drug Procurement by Retail Pharmacies in Yunnan Province", which has detailed regulations on the rights, responsibilities, punishments and incentives of retail pharmacies participating in centralized procurement, and more than 8,400 stores of 73 retail pharmaceutical companies have unified agents with the Yunnan Provincial Drug Circulation Industry Association as a unified agent and unified account
opening on the Yunnan Province Drug Centralized Procurement Platform.
With the acceleration of centralized procurement of drugs into pharmacies, the retail industry is expected to usher in more opportunities, especially the top chain pharmacies will enjoy traffic dividends
.
Relevant data show that within one week of opening pharmacies in Zibo, the sales amount increased by more than 40% on average, the number of drugs sold increased by an average of 46%, and the average patient flow increased by more than
20%.
Previously, in the pilot stage, the pharmacies that could enter the collection of drugs were basically chain pharmacies, and single pharmacies were temporarily excluded
.
According to the "Announcement on the Qualification Confirmation Results of the First Batch of Retail Pharmacies Approved for Participating in Volume-based Procurement of Medical Insurance" issued by the Jiangsu Provincial Medical Insurance Bureau in October, the total number of retail pharmacies approved to participate in volume-based procurement and sunshine procurement is 2,519, of which 1,646 are single pharmacies, accounting for 65%, which has exceeded chain pharmacies
.
And these individual pharmacies are actively embracing "the same price in hospital stores"
.
At present, the first six batches of 7 rounds of drug procurement in China (including "4+7 expansion and centralized procurement") have covered 234 kinds of drugs, involving about 240 billion yuan, accounting for about 30%
of the procurement amount of chemical drugs and biological drugs in public medical institutions.
The seventh batch of selected drugs in the national centralized procurement has also landed in many places recently, involving 60 kinds of drugs, with an average price reduction of 48%, greatly reducing the burden
on patients.
The analysis believes that under the normalization of centralized procurement, the pharmaceutical retail industry is under pressure, and the operation of small and medium-sized enterprises may be unsustainable, and it is expected to gain more opportunities by actively embracing centralized procurement opportunities
.
Centralized procurement of reduced prices, especially some hypertension, diabetes chronic disease drugs into pharmacies, will bring customer flow to pharmacies, is expected to drive the growth of related categories, pharmacy enterprises should seize the opportunity, continue to improve the level of professional services, so as to improve the viscosity of consumers, further enhance their competitiveness
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
